PF-08052667
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-08052667, covering 2026-04-21 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer [Phase 1]